Cell Contraction Assays, Two-Step Attached Model

Cell Contraction Assays, Two-Step Attached Model
  • Uses a 3D collagen matrix to measure changes in the collagen gel size
  • Assess cell contractivity and screen for cell contraction mediators
  • Includes optional cell contraction inhibitor
Email To BuyerPrint this PageCopy Link
Ordering

Please contact your distributor for pricing.

Cell Contraction Assay
Catalog Number
CBA-201
Size
24 assays
Detection
Light Microscopy
Manual/Data Sheet Download
SDS Download
Price
$405.00
Product Details

The two-step attached model combines an initial period of attached matrix contraction leading to mechanical loading, followed by release of the matrices, resulting in mechanical unloading and further contraction as mechanical stress dissipates. Cell Biolabs’ Collagen-based Contraction Assay Kit provides a simple system to assess cell contractivity in vitro and screen cell contraction mediators.

Recent Product Citations
  1. Diao, M. et al. (2022). RAC1 is involved in uterine myometrium contraction in the inflammation-associated preterm birth. Reproduction. 164(4):169-181. doi: 10.1530/REP-21-0186.
  2. Zada, A. et al. (2022). The long Filamin-a isoform is required for intestinal development and motility: implications for chronic intestinal pseudo-obstruction. Hum Mol Genet. doi: 10.1093/hmg/ddac199.
  3. Sheng, F. et al. (2022). Poly amino acid thermosensitive hydrogel loaded with ICG-001 for inhibiting keloid by down-regulating the Wnt/β-Catenin pathway. Mater Des. doi: 10.1016/j.matdes.2022.111050.
  4. Böker, V. et al. (2022). Analysis of genomic alterations in cancer associated human pancreatic stellate cells. Sci Rep. 12(1):13532. doi: 10.1038/s41598-022-17748-1.
  5. Do, D.V. et al. (2022). The Effects of Irisin on the Interaction between Hepatic Stellate Cell and Macrophage in Liver Fibrosis. Endocrinol Metab (Seoul). doi: 10.3803/EnM.2022.1412.
  6. Wei, Y. et al. (2021). Adrenomedullin ameliorates pulmonary fibrosis by regulating TGF-β-Smads signaling and myofibroblast differentiation. Endocrinology. doi: 10.1210/endocr/bqab090.
  7. Zou, Q. et al. (2022). Small extracellular vesicles derived from dermal fibroblasts promote fibroblast activity and skin development through carrying miR-218 and ITGBL1. J Nanobiotechnology. 20(1):296. doi: 10.1186/s12951-022-01499-2.
  8. Hao, M. et al. (2022). Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis. Reprod Biol Endocrinol. 20(1):85. doi: 10.1186/s12958-022-00955-w.
  9. Wang, S. et al. (2022). Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway In Vivo and In vitro. J Clin Transl Hepatol. doi: 10.14218/JCTH.2022.00005.
  10. Lee, K.W. et al. (2022). PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Nat Commun. 13(1):2793. doi: 10.1038/s41467-022-30484-4.
  11. Huang, S. et al. (2022). Tetramethylpyrazine Retards the Progression and Fibrogenesis of Endometriosis. Reprod Sci. doi: 10.1007/s43032-021-00813-x.
  12. Morales, M.M. et al. (2022). A 2D and 3D cell culture protocol to study O-GlcNAc in sphingosine-1-phosphate mediated fibroblast contraction. STAR Protoc. doi: 10.1016/j.xpro.2021.101113.
  13. Kim, J.H. et al. (2021). Insulin-activated store-operated Ca2+ entry via Orai1 induces podocyte actin remodeling and causes proteinuria. Nat Commun. 12(1):6537. doi: 10.1038/s41467-021-26900-w.
  14. Lecce, L. et al. (2021). Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype. J Clin Invest. 131(15):e131178. doi: 10.1172/JCI131178.
  15. Xiao, F. et al. (2021). Tumor-Suppressing STF cDNA 3 Overexpression Suppresses Renal Fibrosis by Alleviating Anoikis Resistance and Inhibiting the PI3K/Akt Pathway. Kidney Blood Press Res. doi: 10.1159/000517318.
  16. Yokota, M. et al. (2021). Staphylococcus aureus impairs dermal fibroblast functions with deleterious effects on wound healing. FASEB J. 35(7):e21695. doi: 10.1096/fj.201902836R.
  17. Morales, M.M. et al. (2021). O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid (LPA)-induced cell contraction in fibroblasts. J Biol Chem. doi: 10.1016/j.jbc.2021.100800.
  18. Zhang, L. et al. (2021). Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy. Cell Death Dis. 12(5):470. doi: 10.1038/s41419-021-03750-4.
  19. Liu, P. et al. (2021). Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells. Drug Des Devel Ther. 15:1653-1666. doi: 10.2147/DDDT.S297500.
  20. Liu, Y. et al. (2021). 20-HETE-promoted cerebral blood flow autoregulation is associated with enhanced pericyte contractility. Prostaglandins Other Lipid Mediat. 154:106548. doi: 10.1016/j.prostaglandins.2021.106548.
  21. Kim, G.R. et al. (2021). MicroRNA-212-5p and its target PAFAH1B2 suppress vascular proliferation and contraction via the downregulation of RhoA. PLoS One. 16(3):e0249146. doi: 10.1371/journal.pone.0249146.
  22. Uemura, M. et al. (2021). Monophasic Pulsed Current Stimulation of Duty Cycle 10% Promotes Differentiation of Human Dermal Fibroblasts into Myofibroblasts. Phys Ther Res. doi: 10.1298/ptr.E10064.
  23. Bai, L. et al. (2020). HDAC5 inhibition reduces angiotensin II-induced vascular contraction, hypertrophy, and oxidative stress in a mouse model. Biomed Pharmacother. 134:111162. doi: 10.1016/j.biopha.2020.111162.
  24. Maun, H.R. et al. (2020). Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge. Nat Commun. 11(1):6435. doi: 10.1038/s41467-020-20143-x.
  25. Pedowitz, N.J. et al. (2020). MYPT1 O-GlcNAc modification regulates sphingosine-1-phosphate mediated contraction. Nat Chem Biol. doi: 10.1038/s41589-020-0640-8.
  26. Yan, D. et al. (2020). Mesothelial Cells Participate in Endometriosis Fibrogenesis Through Platelet-Induced Mesothelial-Mesenchymal Transition. J Clin Endocrinol Metab. doi: 10.1210/clinem/dgaa550.
  27. Ilg, M.M. et al. (2020). Phosphodiesterase Type 5 Inhibitors and Selective Estrogen Receptor Modulators Can Prevent But Not Reverse Myofibroblast Transformation in Peyronie's. J Sex Med. S1743-6095(20)30727-X. doi: 10.1016/j.jsxm.2020.06.022.
  28. Wójcik-Pszczoła, K. et al. (2020). A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling. Int J Mol Sci. 21(11):4008. doi: 10.3390/ijms21114008.
  29. Lin, H. et al. (2020). Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition. Adv Med Sci. 65(2):338-347. doi: 10.1016/j.advms.2020.05.006.
  30. Chow, A. et al. (2020). Dasatinib inhibits peripapillary scleral myofibroblast differentiation. Exp Eye Res. doi: 10.1016/j.exer.2020.107999.